A Driving Simulation study of tolperisone
Phase of Trial: Phase II
Latest Information Update: 26 Jul 2017
At a glance
- Drugs Tolperisone (Primary) ; Cyclobenzaprine
- Indications Muscle spasticity; Spasm
- Focus Therapeutic Use
- 26 Jul 2017 According to a Neurana Pharmaceuticals media release, the company anticipates to have topline results from the study in late third quarter 2017.
- 26 Jul 2017 Status changed from planning to recruiting, according to a Neurana Pharmaceuticals media release.
- 01 Jun 2017 New trial record